About Christopher McLeod
Form D filings for Tangen Biosciences from 2016 to 2023 list Christopher McLeod as director.
Christopher McLeod first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher McLeod in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher McLeod works with at each company, as listed on that company's latest Form D.
Tangen Biosciences, Inc. · Form D, Jun 6, 2023
AL
Alan Levin
Director
RP
Richard Birkmeyer, PhD
President and CEO, director
VK
Vance Kershner
Director
DW
Daniel Wagner
Director
JD
John Davidson
Executive officer and director